不同大血管闭塞性急性缺血性卒中患者静脉溶栓疗效比较

摘要/Abstract

摘要：

目的对不同大血管闭塞所致的急性缺血性卒中患者静脉溶栓疗效进行比较分析，探讨适宜静脉溶栓治疗的大血管闭塞患者。方法本研究的入选患者来自中国急性缺血性卒中溶栓监测登记研究，从中选取所有完成了溶栓前多模式计算机断层扫描（computed tomography，CT）或磁共振成像（magnetic resonance imaging，MRI），且血管成像提示有责任大血管闭塞的患者，对不同大血管闭塞的急性缺血性卒中患者静脉溶栓的有效性及安全性结局进行比较分析。结果共入选122例患者，大脑中动脉闭塞组溶栓后血管再通率为55.2%，而颈内动脉闭塞组为0%，基底动脉闭塞组为40%。大脑中动脉闭塞组90 d随访生活自理［53.9% vs 21.1%，P =0.007，比值比（odds ratio，OR）=5.68］及良好预后（42.7% vs 21.1%，P =0.041，OR =3.76）的比例均优于颈内动脉闭塞组，死亡率低于颈内动脉闭塞组（4.5% vs 47.4%，P <0.001，OR =0.03），而两组溶栓后的症状性颅内出血发生率差异无显著性（1.1% vs 0%，P =0.962）。结论不同大血管闭塞性急性缺血性卒中患者静脉溶栓效果有明显差异，大脑中动脉闭塞患者静脉溶栓开通率最高，疗效明显优于颈内动脉闭塞患者。

文章导读： 本研究显示组织型纤溶酶原激活剂静脉溶栓治疗大血管闭塞所致急性缺血性卒中，其中大脑中动
脉闭塞患者血管开通率高于其他大动脉闭塞者，且其治疗的预后好于颈内动脉闭塞患者。

关键词: 急性缺血性卒中; 大血管闭塞; 溶栓; 疗效

Abstract:

Objective To compare the intravenous thrombolytic therapeutic effect of the acute ischemic stroke patients with different large vessel occlusion and to investigate which occlusion subtype of patients are suitable for intravenous thrombolytic treatment. Methods Data were analyzed from the Thrombolysis Implementation and Monitoring of Acute Ischemic Stroke in China (TIMS-China). Patients who accomplished multiple parameter computed tomography (CT) or magnetic resonance (MR) and CT angiography or MR angiography showed large vessel occlusion were included. The safety and efficacy outcome were compared. Results A total of 122 patients were included. The rates of recanalization were:middle cerebral artery (MCA) occlusion group 55.2%, internal carotid artery (ICA) occlusion group 0% and basilar artery (BA) occlusion group 40%. For the functional independence outcome at 90 days, MCA occlusion group was significantly better than ICA occlusion group (53.9% vs 21.1%, P =0.007, [odds ratio, OR]=5.68). For excellent recovery outcome at 90 days, MCA occlusion group was also significantly better than ICA occlusion group (42.7% vs 21.1%, P =0.041, OR=3.76). For mortality, MCA group was significantly lower than ICA group (4.5% vs 47.4%, P <0.001, OR =0.03). There were no significant differences between MCA group and ICA group in the symptomatic intracranial hemorrhage (1.1% vs 0%, P =0.962). Conclusion The intravenous thrombolytic therapeutic effect of the acute ischemic stroke patients with different large vessel occlusion was significantly different. The recanalization rate of MCA occlusion group was highest, and the therapeutic effect was significantly better than ICA occlusion group.

Key words: Acute ischemic stroke; Large vessel occlusion; Thrombolytic treatment; Therapeutic effect

廖晓凌1，王伊龙1，2，潘岳松1，王春娟1，赵性泉1，王春雪1，刘丽萍1，王拥军1. 不同大血管闭塞性急性缺血性卒中患者静脉溶栓疗效比较[J]. 中国卒中杂志, 2014, 9(04): 278-284.

LIAO Xiao-Ling*, WANG Yi-Long, PAN Yue-Song,WANG Chun-Juan, ZHAO Xing-Quan, WANG Chun-Xue, LIU Li-Ping, WANG Yong-Jun.. Comparison of Intravenous Thrombolytic Effect of Acute Ischemic Stroke Patients
with Different Large Vessel Occlusion[J]. Chinese Journal of Stroke, 2014, 9(04): 278-284.

参考文献

1 The National Institute of Neurological Disorders and

Stroke rt-PA Stroke Study Group. Tissue plasminogen

activator for acute ischemic stroke[J]. N Engl J Med,

1995, 333:1581-1587.

2 Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis

with alteplase 3 to 4.5 hours after acute ischemic

stroke[J]. N Engl J Med, 2008, 359:1317-1329.

3 Liao XL, Wang CX, Wang YL, et al. Implementation

and outcome of thrombolysis with alteplase 3 to

4.5h after acute stroke in Chinese patients[J]. CNS Neurosci Ther, 2013, 19:43-47.

4 Tomsick T, Brode r ick J, Ca r roz el l a J, e t a l .

Revascularization results in the Interventional

Management of Stroke II trial[J]. AJNR Am J

Neuroradiol, 2008, 29:582-587.

5 Hallevi H, Grotta JC. SITS-MOST:old myths laid to

rest[J]. Lancet Neurol, 2007, 6:292-293.

6 Mullen MT, Pisapia JM, Tilwa S, et al. Systematic

review of outcome after ischemic stroke due to

anterior circulation occlusion treated with intravenous,

intra-arterial, or combined intravenous+intra-arterial

thrombolysis[J]. Stroke, 2012, 43:2350-2355.

7 Linfante I, Llinas RH, Selim M, et al. Clinical and

vascular outcome in internal carotid artery versus middle

cerebral artery occlusions after intravenous tissue

plasminogen activator[J]. Stroke, 2002, 33:2066-2071.

8 Sanak D, Herzig R, Skoloudik D, et al. The safety

and eff icacy of continuous transcranial duplex

Doppler monitor ing of middle cerebral ar ter y

occlusion in acute stroke patients:comparison of

TCDD and thrombolysis in MCA recanalization[J]. J

Neuroimaging, 2010, 20:58-63.

9 Wunderlich MT, Stolz E, Seidel G, et al. Conservative

medical treatment and intravenous thrombolysis in

acute stroke from carotid T occlusion[J]. Cerebrovasc

Dis, 2005, 20:355-61.

10 De Silva DA, Brekenfeld C, Ebinger M, et al. The

benefits of intravenous thrombolysis relate to the

site of baseline arterial occlusion in the Echoplanar

Imaging Thrombolytic Evaluation Trial (EPITHET)[J].

Stroke, 2010, 41:295-299.

11 Khar itonova TV, Melo TP, Andersen G, et al.

Importance of cerebral artery recanalization in

patients with stroke with and without neurological

improvement after intravenous thrombolysis[J].

Stroke, 2013, 44:2513-2518.

12 Kha r itonova T, Mi k ul i k R, Roi ne RO, e t a l.

Association of early National Institutes of Health

Stroke Scale improvement with vessel recanalization

and functional outcome after intravenous thrombolysis

in ischemic stroke[J]. Stroke, 2011, 42:1638-1643.

13 Bhatia R, Hill MD, Shobha N, et al. Low rates of

acute recanalization with intravenous recombinant

tissue plasminogen activator in ischemic stroke:realworld

experience and a call for action[J]. Stroke, 2010,

41:2254-2258.

14 Lindsberg PJ, Mattle HP. Therapy of basilar artery

occlusion:a systematic analysis comparing intraarterial

and intravenous thrombolysis[J]. Stroke, 2006,

37:922-928.

15 van der Hoeven EJ, Schonewille WJ, Vos JA, et al.The Basilar Artery International Cooperation Study

(BASICS):study protocol for a randomised controlled

trial[J]. Trials, 2013, 14:200.

16 Schonewille WJ, Wijman CA, Michel P, et al.

Treatment and outcomes of acute basilar artery

occlusion in the Basila r Ar ter y Inter nat ional

Cooperation Study (BASICS):a prospective registry

study[J]. Lancet Neurol, 2009, 8:724-730.

[1]	鲁燕, 杨保荣, 黄向萍, 杨冠桂, 陈圣文, 李建荣, 曾小明. 县级医院急性缺血性卒中超时间窗经MRI筛选溶栓的病例对照研究 [J]. 中国卒中杂志, 2022, 17(12): 1321-1326.
[2]	向薇, 徐璐瑶, 张曼曼, 魏红春, 梁志刚. 缺血性卒中急性期磁敏感加权成像不对称突出静脉征的发生率及影响因素分析[J]. 中国卒中杂志, 2022, 17(10): 1097-1102.
[3]	张伯煜, 郭玉成, 崔玉霞, 李英丽, 吕雨梅. 急性缺血性卒中患者就医行为决策现状及影响因素研究进展[J]. 中国卒中杂志, 2022, 17(10): 1127-1132.
[4]	吴亭亭, 刘亚飞, 闫世曦, 武一平, 张忠波, 张邯菲, 房娉平. “互联网+”在急性缺血性卒中救治中的应用进展[J]. 中国卒中杂志, 2022, 17(10): 1133-1138.
[5]	刘承春, 唐春花, 黄书翰, 吴娅, 李小树, 李玮, 张猛. 伴大核心梗死的前循环串联闭塞的急性期同期血管内治疗研究[J]. 中国卒中杂志, 2022, 17(08): 834-839.
[6]	郑玮, 翟华筝, 陈萌萌, 汪敬业. 直接取栓与桥接治疗对急性大血管闭塞性缺血性卒中疗效比较的荟萃分析[J]. 中国卒中杂志, 2022, 17(07): 720-729.
[7]	周娟, 谭云宾, 王铁军, 石富铭, 余苹. 急性缺血性卒中患者住院期间照顾者焦虑抑郁的发生率及影响因素分析[J]. 中国卒中杂志, 2022, 17(07): 764-768.
[8]	王卫, 赵尚峰, 张宝瑞, 梁熙虹, 康军. 超选动脉内溶栓治疗急性视网膜中央动脉闭塞的疗效探讨[J]. 中国卒中杂志, 2022, 17(07): 774-779.
[9]	玄桂英, 范彩丽, 玄丽霞, 赵倩倩, 李雪梅. 新型冠状病毒肺炎疫情期间急性缺血性卒中患者门诊随诊失访原因分析[J]. 中国卒中杂志, 2022, 17(06): 648-652.
[10]	张东, 李治璋, 马瑞楠, 岳蕴华. 应激性高血糖比值与急性缺血性卒中患者临床预后的相关性研究[J]. 中国卒中杂志, 2022, 17(05): 483-490.
[11]	李振华, 刘著, 胡全忠. 非致残性缺血性脑血管事件药物治疗进展[J]. 中国卒中杂志, 2022, 17(04): 407-412.
[12]	黄妍, 付学军, 史会杰, 邹良玉. 三酰甘油-葡萄糖指数与急性缺血性卒中神经功能缺损的相关性分析[J]. 中国卒中杂志, 2022, 17(03): 251-257.
[13]	刘忠, 刘媛媛, 徐少峰, 郭伟, 康海. 系统免疫炎性指数与急性缺血性卒中严重程度及预后的相关性分析[J]. 中国卒中杂志, 2022, 17(03): 285-291.
[14]	李力卓, 胡悦, 何松柏, 杨玉瑶, 宋灏哲, 王勇, 李凤杰, 单志刚, 郭伟. 助力健康——移动卒中单元在行动[J]. 中国卒中杂志, 2022, 17(02): 107-111.
[15]	郭松韬, 额布, 李智强, 姜昊, 许玉柱, 孙舰, 史建民, 吴喜, 郭伟. 第五代移动通信技术移动卒中单元的研究进展[J]. 中国卒中杂志, 2022, 17(02): 113-117.